A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
Authors
Keywords
-
Journal
Molecular Therapy-Nucleic Acids
Volume 29, Issue -, Pages 413-425
Publisher
Elsevier BV
Online
2022-07-21
DOI
10.1016/j.omtn.2022.07.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System
- (2022) Daniel Meraviglia-Crivelli et al. Biomedicines
- The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma
- (2021) Jacob T Polaski et al. eLife
- Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
- (2021) Claire Lhuillier et al. JOURNAL OF CLINICAL INVESTIGATION
- Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
- (2021) Rianne D. W. Vaes et al. Cells
- NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
- (2021) Jonas P. Becker et al. iScience
- Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy
- (2021) Roberta Bongiorno et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
- (2020) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
- (2020) Kevin Litchfield et al. Nature Communications
- Quality and quantity control of gene expression by nonsense-mediated mRNA decay
- (2019) Tatsuaki Kurosaki et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic applications of AS1411 aptamer, an update review
- (2019) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
- (2019) Rik G. H. Lindeboom et al. NATURE GENETICS
- Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response
- (2019) Jennifer L. Johnson et al. NEURON
- Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
- (2019) Greta Garrido et al. Nature Communications
- Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltration
- (2019) Boyang Zhao et al. PLoS Computational Biology
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
- (2018) Brett Schrand et al. Nature Communications
- Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
- (2018) A’dem Bokhari et al. Oncogenesis
- Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
- (2018) David Egg et al. Frontiers in Immunology
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers for immunotherapy in bladder cancer: a moving target
- (2017) David H. Aggen et al. Journal for ImmunoTherapy of Cancer
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors
- (2016) JingWei Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
- (2015) Sebastien A. Burel et al. NUCLEIC ACIDS RESEARCH
- Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics
- (2015) Maximilian W. Popp et al. Nature Communications
- 5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
- (2014) M. Bhuvanagiri et al. EMBO Molecular Medicine
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma
- (2014) Chen Liu et al. NATURE MEDICINE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Liver as a target for oligonucleotide therapeutics
- (2013) Alfica Sehgal et al. JOURNAL OF HEPATOLOGY
- Smg1 haploinsufficiency predisposes to tumor formation and inflammation
- (2013) Tara L. Roberts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination
- (2013) Adam J Litterman et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started